Check Yourself — Lesson 2

Answers to Exercise 2

1. For what medical treatment(s) is vatalanib being developed?
   age-related macular degeneration
   colorectal cancer
   nonsmall cell lung cancer
   malignant mesothelioma
   multiple myeloma
   pancreatic cancer
   prostate cancer
2. In which countries has vatalanib received patent protection?
   Switzerland and WO (World Treaty Organization)
3. What is the laboratory code for vatalanib?
   PTK/ZK; PTK 787; ZK 222584; CGP 79787D; CGP 79787; PTK 7871
4. What area does IMS R&D Focus have that other drug pipeline databases do not?
   Nomenclature
5. Who is the licensee?
   Novartis
6. Who holds the patent for vatalanib?
   Novartis
7. Does vatalanib have a brand name? What does the name vatalanib represent in the nomenclature?
   Not yet, according to the document at hand. The name vatalanib is the preferred International Nonproprietary Name (INN) and the U.S. Adopted Name (USAN)—generic name.
8. What prefix would you use to search for the name vatalanib?
   Use drug name NA= or /NA
9. What prefix would you use to search for the therapeutic class code?
   Use TC= or /TC
10. Write the search strategy to search for the laboratory code for vatalanib.
    S CD=( PTK 787 or ZK 222584 or CGP 79787D)

Close this window when you're done and return to the lesson.

---

Print page